Disparities in acute myeloid leukemia treatments and outcomes
AK Eisfeld - Current Opinion in Hematology, 2024 - journals.lww.com
An increasing number of studies have not only shown persistent survival disparities between
Black and non-Hispanic White AML patients, but uncovered a multitude of contributors that …
Black and non-Hispanic White AML patients, but uncovered a multitude of contributors that …
High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML
Survival of patients with acute myeloid leukemia (AML) is inversely associated with age, but
the impact of race on outcomes of adolescent and young adult (AYA; range, 18-39 years) …
the impact of race on outcomes of adolescent and young adult (AYA; range, 18-39 years) …
From Descriptive to Functional Genomics of Leukemias Focusing on Genome Engineering Techniques
Genome engineering makes the precise manipulation of DNA sequences possible in a cell.
Therefore, it is essential for understanding gene function. Meganucleases were the start of …
Therefore, it is essential for understanding gene function. Meganucleases were the start of …
Association of social deprivation with survival in younger adult patients with AML: an Alliance study
M Rebechi, J Kohlschmidt, K Mrózek, D Nicolet… - Blood …, 2023 - ashpublications.org
Cancer health disparities are differences in health outcomes observed across population
groups, including patients with acute myeloid leukemia (AML), characterized by various …
groups, including patients with acute myeloid leukemia (AML), characterized by various …
The clinical implications of BCOR mutations in a large cohort of acute myeloid leukemia patients: a 5-year single-center retrospective study
D Hu, K Shen, YS Guo, X Bao, N Dong… - Leukemia & …, 2024 - Taylor & Francis
To elucidate the effect of BCOR mutation (BCOR mut) on clinical outcomes, we included a
total of 899 consecutive AML patients in a single-center during July 2016 to December 2021 …
total of 899 consecutive AML patients in a single-center during July 2016 to December 2021 …
Jumping translocation involving chromosome 13q in a patient with Crohn's Disease and inv (16)(p13. 1q22)/CBFB-MYH11 acute myeloid leukemia
S Clarke, R de Kraa, H Chuah, K Creeper, MF Leahy… - Cancer Genetics, 2022 - Elsevier
Jumping translocations (JT) are rare chromosomal rearrangements caused by the
translocation of one donor chromosome segment to two or more recipient chromosomes. In …
translocation of one donor chromosome segment to two or more recipient chromosomes. In …
Case Report: Successful therapy with all-trans retinoic acid combined with chemotherapy followed by hematopoietic stem cell transplantation for acute promyelocytic leukemia …
Acute promyelocytic leukemia (APL) is characterized by the balanced translocation of
chromosomes 15 and 17, resulting in the formation of PML-RARA fusion gene. More than …
chromosomes 15 and 17, resulting in the formation of PML-RARA fusion gene. More than …
OPEN ACCESS EDITED BY
JL Spivak, GA Croci, SS Chuang… - Case Reports in …, 2023 - books.google.com
Langerhans cell histiocytosis (LCH) and acute myeloid leukemia (AML) are distinct entities
of blood neoplasms, and the exact developmental origin of both neoplasms is considered to …
of blood neoplasms, and the exact developmental origin of both neoplasms is considered to …
Clinical exome sequencing reveals an important role for clinical diagnosis of intellectual disability with definition of seven novel variants.
Intellectual disability can be defined as a significantly below-average general mental
function, accompanied by environmental adaptation and behavioural deterioration. Patient …
function, accompanied by environmental adaptation and behavioural deterioration. Patient …
Crenolanib for treating flt3 mutated proliferative disorders associated mutations
VK Jain - US Patent App. 17/667,781, 2022 - Google Patents
The present invention includes methods for treating a human patient with Crenolanib,
wherein the human patient is suffering from a FLT3 mutated leukemia, the method …
wherein the human patient is suffering from a FLT3 mutated leukemia, the method …